ContextThe timing of initiation of hormone therapy may influence its effect on cardiovascular
disease.ObjectiveTo explore whether the effects of hormone therapy on risk of …

ContextDespite decades of accumulated observational evidence, the balance of risks and
benefits for hormone use in healthy postmenopausal women remains uncertain.ObjectiveTo …

Background The role of walking, as compared with vigorous exercise, in the prevention of
cardiovascular disease remains controversial. Data for women who are members of minority …

Background Guidelines established by the National Cholesterol Education Program (NCEP)
promote exercise and weight loss for the treatment of abnormal lipoprotein levels. Little is …

ContextThe Women's Health Initiative Estrogen-Aone trial comparing conjugated equine
estrogens (CEE) with placebo was stopped early because of an increased stroke incidence and …

ContextMultiple epidemiologic studies and some trials have linked diet with cardiovascular
disease (CVD) prevention, but long-term intervention data are needed.ObjectiveTo test the …

We studied separately the influence of two methods for losing fat weight on the levels of plasma
lipids and lipoproteins in overweight sedentary men — decreasing energy intake without …

Background Although exercise parameters such as intensity and format have been shown
to influence exercise participation rates and physiological outcomes in the short term, few …

ContextThe Women's Health Initiative trial of combined estrogen plus progestin was
stopped early when overall health risks, including invasive breast cancer, exceeded benefits. …

Background The efficacy of calcium with vitamin D supplementation for preventing hip and
other fractures in healthy postmenopausal women remains equivocal. Methods We recruited …